ONCS Insider Trading - OncoSec Medical Inc

Innsideraksjer

303 837 shares

Insider Sentiment Score

Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.

Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.

Se høyest rangerte aksjer

Officer Sentiment Score

Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.

Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.

Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.

Se høyest rangerte aksjer

Nøkkelindikatorer for insidere

Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.

For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).

Netto antall insidere som kjøper (Rangering)

N/A

Nettotall av innsidekjøp som kjøper er det totale antallet insidere som har kjøpt minus det totale antallet insidere som har solgt de siste 90 dagene. Den prosentvise rangeringen vises her (rangerer fra 0 til 100%).

Prosent av aksjeflyt kjøpt av insidere (rang)

N/A

Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.

Diagram over innsidehandel

OncoSec Medical Inc insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.

Insiderliste og lønnsomhetsmålinger

Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.

See our leaderboard of most profitable insider traders.

Innsider	Gjennomsnittlig fortjeneste (%)	Aksjer eid	Splitt justert

Report errors via our new Insider Auditing Tool

Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse

I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i ONCS / OncoSec Medical Inc. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til maks	Pris ved maks	Maks fortjeneste	Maks avkastning (%)
2021-08-23	DALESANDRO MARGARET	20 000	1,8900	909	41,5800	37 800	8	51.48	8 995	23,80
2021-08-23	Zhao Yuhang	4 000	1,8800	182	41,3600	7 520
2021-08-20	Zhao Yuhang	8 000	1,9400	364	42,6800	15 520
2021-04-16	China Grand Pharmaceutical & Healthcare Holdings Ltd	1 409 838	3,4500	64 084	75,9000	4 863 941
2021-04-16	China Grand Pharmaceutical & Healthcare Holdings Ltd	281 968	3,4500	12 817	75,9000	972 790
2021-01-25	China Grand Pharmaceutical & Healthcare Holdings Ltd	677 839	5,4500	30 811	119,9000	3 694 223
2021-01-25	China Grand Pharmaceutical & Healthcare Holdings Ltd	3 389 198	5,4500	154 054	119,9000	18 471 129
2020-08-19	China Grand Pharmaceutical & Healthcare Holdings Ltd	399 800	3,2500	18 173	71,5000	1 299 350
2020-08-19	China Grand Pharmaceutical & Healthcare Holdings Ltd	1 999 000	3,2500	90 864	71,5000	6 496 750

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

ONCS / OncoSec Medical Inc Insider Trades

Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse

I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i ONCS / OncoSec Medical Inc. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til min	Pris ved min	Maks tap ungått ($)	Maks tap ungått (%)
2023-02-09	DelAversano Robert J	40	1,3700	40	1,3700	55	132	0.1951	−46	−85,55
2022-11-04	DelAversano Robert J	283	0,3700	13	8,1400	105
2022-08-05	DelAversano Robert J	284	0,7100	13	15,6200	202
2022-05-06	DelAversano Robert J	274	0,8300	12	18,2600	227
2022-02-09	DelAversano Robert J	409	0,8800	19	19,3600	360
2021-11-01	DelAversano Robert J	343	1,7500	16	38,5000	600
2021-08-02	DelAversano Robert J	412	2,1800	19	47,9600	898
2021-06-28	Leuthner Brian A	13 613	3,1600	619	69,5200	43 017
2021-05-03	DelAversano Robert J	453	4,8600	21	106,9200	2 202

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

Transaksjonshistorikk

Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.

Fil dato	Handels dato	Skjema	Innsider	Ticker	Verdipapirnavn	Kode	Direkte	Utøvelses pris	Enhets pris	Enheter endret	Verdi endret (1K)	Gjenværende Opsjoner	Gjenværende Aksjer
2023-02-09	2023-02-09	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		1,3700	−40	−0		1 008
2022-11-04	2022-11-04	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		0,3700	−283	−0		22 975
2022-08-05	2022-08-05	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		0,7100	−284	−0		23 258
2022-05-06	2022-05-06	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		0,8300	−274	−0		23 542
2022-05-03	2022-05-02	4	Arch Robert H.	ONCS	Stock Option (right to buy)	A - Award	D	0,84		700 000		700 000
2022-02-11	2022-02-09	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		0,8800	−409	−0		23 816
2021-11-03	2021-11-01	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		1,7500	−343	−1		24 225
2021-08-25	2021-08-23	4	DALESANDRO MARGARET	ONCS	Common Stock	P - Purchase	D		1,8900	20 000	38		20 000
2021-08-24	2021-08-23	4	Zhao Yuhang	ONCS	Common Stock	P - Purchase	D		1,8800	4 000	8		12 000
2021-08-24	2021-08-20	4	Zhao Yuhang	ONCS	Common Stock	P - Purchase	D		1,9400	8 000	16		8 000
2021-08-03	2021-08-02	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		2,1800	−412	−1		24 568
2021-06-29	2021-06-28	4	DEMESA JAMES M	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	DelAversano Robert J	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		35 000		35 000
2021-06-29	2021-06-28	4	Smith Kevin Raymond Merrill	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	Leuthner Brian A	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		33 000		33 000
2021-06-29	2021-06-28	4	Leuthner Brian A	ONCS	Common Stock	S - Sale	D		3,1600	−13 613	−43		178 387
2021-06-29	2021-06-28	4	Leuthner Brian A	ONCS	Common Stock	A - Award	D			192 000			192 000
2021-06-29	2021-06-28	4	Zhou Chao	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	Zhao Yuhang	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	Lyerly Herbert Kim	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	Ward Robert	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	Kim Joon	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		25 000		25 000
2021-06-29	2021-06-28	4	DALESANDRO MARGARET	ONCS	Stock Option (Right to Buy)	A - Award	D	3,16		37 500		37 500
2021-05-04	2021-04-30	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		4,8600	−3 172	−15		96 097
2021-05-04	2021-05-03	4	DelAversano Robert J	ONCS	Common Stock	S - Sale	D		4,8600	−453	−2		24 980
2021-04-26	2021-04-16	4	China Grand Pharmaceutical & Healthcare Holdings Ltd	ONCS	Common Stock	P - Purchase	I		3,4500	281 968	973		3 359 607
2021-04-26	2021-04-16	4	China Grand Pharmaceutical & Healthcare Holdings Ltd	ONCS	Common Stock	P - Purchase	I		3,4500	1 409 838	4 864		16 798 036
2021-02-23	2021-02-18	4	Alpha Holdings, Inc.	ONCS	Warrants to Purchase Common Stock	X - Other	D	3,45	0,0100	368 250	4	0
2021-02-23	2021-02-18	4	Alpha Holdings, Inc.	ONCS	Common Stock	X - Other	D		3,4500	368 250	1 270		1 718 251
2021-02-17	2021-02-02	4	Leuthner Brian A	ONCS	Stock Option(Right to Buy)	A - Award	D	7,45		150 000		150 000
2021-02-03	2021-02-01	4	DelAversano Robert J	ONCS	Common Stock	A - Award	D			8 750			25 433
2021-02-02	2021-02-01	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		7,7100	−3 413	−26		99 269
2021-01-27	2021-01-25	4	China Grand Pharmaceutical & Healthcare Holdings Ltd	ONCS	Common Stock	P - Purchase	I		5,4500	677 839	3 694		3 077 639
2021-01-27	2021-01-25	4	China Grand Pharmaceutical & Healthcare Holdings Ltd	ONCS	Common Stock	P - Purchase	I		5,4500	3 389 198	18 471		15 388 198
2020-11-23	2020-11-20	4	Alpha Holdings, Inc.	ONCS	Common Stock	S - Sale	D		4,9234	−80 000	−394		1 350 001
2020-11-20	2020-11-19	4	Alpha Holdings, Inc.	ONCS	Common Stock	S - Sale	D		5,1046	−50 000	−255		1 430 001
2020-11-19	2020-11-18	4	Alpha Holdings, Inc.	ONCS	Common Stock	S - Sale	D		5,2416	−10 999	−58		1 480 001
2020-11-19	2020-11-18	4	Alpha Holdings, Inc. By Alpha Biolabs	ONCS	Common Stock	S - Sale	I		5,2416	−40 000	−210		1 491 000
2020-11-18	2020-11-17	4	Alpha Holdings, Inc. By Alpha Biolabs	ONCS	Common Stock	S - Sale	I		5,1686	−40 000	−207		1 531 000
2020-11-18	2020-11-16	4	Alpha Holdings, Inc. By Alpha Biolabs	ONCS	Common Stock	S - Sale	I		5,4082	−40 000	−216		1 571 000
2020-11-03	2020-11-02	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		3,7900	−3 280	−12		102 682
2020-09-16	2020-09-14	4	Lyerly Herbert Kim	ONCS	Stock Option (Right to Buy)	A - Award	D	3,43		25 000		25 000
2020-09-16	2020-09-14	4	DEMESA JAMES M	ONCS	Stock Option (Right to Buy)	A - Award	D	3,43		50 000		50 000
2020-09-16	2020-09-14	4	DALESANDRO MARGARET	ONCS	Stock Option (Right to Buy)	A - Award	D	3,43		25 000		25 000
2020-09-16	2020-09-14	4	Ward Robert	ONCS	Stock Option (Right to Buy)	A - Award	D	3,43		25 000		25 000
2020-08-26	2020-08-24	4	Foerter Kellie Malloy	ONCS	Stock Option (Right to Buy)	A - Award	D	3,82		65 000		65 000
2020-08-26	2020-08-24	4	DelAversano Robert J	ONCS	Stock Option (Right to Buy)	A - Award	D	3,82		27 000		27 000
2020-08-26	2020-08-24	4	O'Connor Daniel	ONCS	Stock Option (Right to Buy)	A - Award	D	3,82		152 000		152 000
2020-08-21	2020-08-19	4	China Grand Pharmaceutical & Healthcare Holdings Ltd	ONCS	Common Stock	P - Purchase	I		3,2500	399 800	1 299		2 399 800
2020-08-21	2020-08-19	4	China Grand Pharmaceutical & Healthcare Holdings Ltd	ONCS	Common Stock	P - Purchase	I		3,2500	1 999 000	6 497		11 999 000
2020-08-05		3	Foerter Kellie Malloy	ONCS	Common Stock		D						62 988
2020-08-05		3	Foerter Kellie Malloy	ONCS	Common Stock		D						62 988
2020-08-05		3	Foerter Kellie Malloy	ONCS	Common Stock		D						62 988
2020-08-05	2020-07-27	4	Foerter Kellie Malloy	ONCS	Stock Option (Right to Buy)	A - Award	D	3,30		30 000		30 000
2020-08-04	2020-07-31	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		4,2000	−3 133	−13		105 962
2020-06-03	2020-05-29	4	Zhou Chao	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		25 000		25 000
2020-06-03	2020-05-29	4	DelAversano Robert J	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		54 054		54 054
2020-06-03	2020-05-29	4	DelAversano Robert J	ONCS	Common Stock	F - Taxes	D		2,2300	−8 679	−19		16 683
2020-06-03	2020-05-29	4	DelAversano Robert J	ONCS	Common Stock	A - Award	D			25 362			25 362
2020-06-03	2020-05-29	4	Smith Kevin Raymond Merrill	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		25 000		25 000
2020-06-03	2020-05-29	4	Ward Robert	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		25 000		25 000
2020-06-03	2020-05-29	4	Zhao Yuhang	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		25 000		25 000
2020-06-03	2020-05-29	4	DALESANDRO MARGARET	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		37 500		37 500
2020-06-03	2020-05-29	4	Lyerly Herbert Kim	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		25 000		25 000
2020-06-03	2020-05-29	4	O'Connor Daniel	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		304 000		304 000
2020-06-03	2020-05-29	4	O'Connor Daniel	ONCS	Common Stock	F - Taxes	D		2,2300	−44 471	−99		109 095
2020-06-03	2020-05-29	4	O'Connor Daniel	ONCS	Common Stock	A - Award	D			90 580			153 566
2020-06-03	2020-05-29	4	Kim Joon	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		25 000		25 000
2020-06-03	2020-05-29	4	DEMESA JAMES M	ONCS	Stock Option (Right to Buy)	A - Award	D	1,56		37 500		37 500
2020-05-04	2020-04-30	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		1,7900	−3 075	−6		62 986
2020-04-21	2020-04-17	4	DHILLON AVTAR S	ONCS	Common Stock	A - Award	D		1,5500	12 500	19		62 052
2020-02-19		3/A	Sirtex Medical US Holdings, Inc.	ONCS	Common Stock		I						12 000 000
2020-02-18		3	Sirtex Medical US Holdings, Inc.	ONCS	Common Stock		I						24 000 000
2020-02-18		3	Sirtex Medical US Holdings, Inc.	ONCS	Common Stock		I						24 000 000
2020-02-18		3	Sirtex Medical US Holdings, Inc.	ONCS	Common Stock		I						24 000 000
2020-02-18		3	Sirtex Medical US Holdings, Inc.	ONCS	Common Stock		I						24 000 000
2020-02-03	2020-01-31	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		1,9600	−2 654	−5		66 061
2020-01-21	2020-01-16	4	Bonstein Sara	ONCS	Common Stock	S - Sale	D		2,0800	−1 351	−3		41 389
2019-11-01	2019-10-31	4	O'Connor Daniel	ONCS	Common Stock	S - Sale	D		2,1600	−2 128	−5		68 715
2019-10-18	2019-10-16	4	Bonstein Sara	ONCS	Common Stock	S - Sale	D		2,0100	−1 111	−2		42 740
2019-08-02	2019-07-31	4	O'Connor Daniel	ONCS	Common Stock	F - Taxes	D		2,2300	−2 156	−5		70 843
2019-07-19	2019-07-17	4	Alpha Holdings, Inc. By Alpha Biolabs	ONCS	Common Stock	P - Purchase	I		2,5700	30 000	77		1 611 000
2019-07-18	2019-07-16	4	Bonstein Sara	ONCS	Common Stock	F - Taxes	D		2,4200	−1 111	−3		43 851
2019-07-17	2019-07-16	4	Alpha Holdings, Inc. By Alpha Biolabs	ONCS	Common Stock	P - Purchase	I		2,3400	60 000	140		1 581 000
2019-07-17	2019-07-15	4	Alpha Holdings, Inc. By Alpha Biolabs	ONCS	Common Stock	P - Purchase	I		2,2200	30 000	67		1 521 000
2019-05-28	2019-05-22	4/A	Alpha Holdings, Inc.	ONCS	Warrants to Purchase Common Stock	P - Purchase	D	3,45	0,0100	368 250	4	368 250
2019-05-28	2019-05-22	4/A	Alpha Holdings, Inc.	ONCS	Common Stock	P - Purchase	D		3,1400	491 000	1 542		1 491 000
2019-05-24	2019-05-22	4	Alpha Holdings, Inc.	ONCS	Warrants to Purchase Common Stock	P - Purchase	D	3,45	0,0100	368 250	4	368 250
2019-05-24	2019-05-22	4	Alpha Holdings, Inc.	ONCS	Common Stock	P - Purchase	D		3,1400	491 000	1 542		10 491 000
2019-05-02	2019-04-30	4	O'Connor Daniel	ONCS	Common Stock	F - Taxes	D		0,5650	−21 357	−12		729 992
2019-04-26	2019-04-24	4	DALESANDRO MARGARET	ONCS	Stock Option (Right to Buy)	A - Award	D	0,58		100 000		100 000
2019-04-18	2019-04-16	4	Bonstein Sara	ONCS	Common Stock	F - Taxes	D		0,6001	−11 102	−7		449 629
2019-02-01	2019-01-31	4	O'Connor Daniel	ONCS	Common Stock	F - Taxes	D		0,8800	−25 318	−22		751 349
2019-01-18	2019-01-16	4	Bonstein Sara	ONCS	Common Stock	F - Taxes	D		0,6850	−13 379	−9		460 731
2019-01-04	2019-01-02	4	Mayes, Gregory T.	ONCS	Stock Option (Right to Buy)	A - Award	D	0,66		50 000		50 000
2019-01-04	2019-01-02	4	DHILLON AVTAR S	ONCS	Stock Option (Right to Buy)	A - Award	D	0,66		50 000		50 000
2019-01-04	2019-01-02	4	Kim Joon	ONCS	Stock Option (Right to Buy)	A - Award	D	0,66		50 000		50 000
2019-01-04	2019-01-02	4	DHILLON PUNIT	ONCS	Stock Option (Right to Buy)	A - Award	D	0,66		50 000		50 000
2019-01-04	2019-01-02	4	DEMESA JAMES M	ONCS	Stock Option (Right to Buy)	A - Award	D	0,66		225 000		225 000
2019-01-04	2019-01-02	4	Ward Robert	ONCS	Stock Option (Right to Buy)	A - Award	D	0,66		50 000		50 000
2018-12-27	2018-12-24	4	O'Connor Daniel	ONCS	Common Stock	A - Award	D			750 000			776 667
2018-12-27	2018-12-24	4	Bonstein Sara	ONCS	Stock Option (Right to Buy)	A - Award	D	0,60		165 000		165 000
2018-12-17	2018-12-17	4	DEMESA JAMES M	ONCS	Common Stock	A - Award	D		0,7700	1 500	1		22 501
2018-12-11		3	Alpha Holdings, Inc.	ONCS	Common Stock		D						20 000 000
2018-12-11		3	Alpha Holdings, Inc.	ONCS	Common Stock		D						20 000 000
2018-12-11		3	Alpha Holdings, Inc.	ONCS	Common Stock		D						20 000 000
2018-11-26	2018-11-20	4	DEMESA JAMES M	ONCS	Common Stock	P - Purchase	D		0,8000	7 000	6		21 001
2018-11-26	2018-11-07	4	DEMESA JAMES M	ONCS	Common Stock	P - Purchase	D		0,9100	1 500	1		14 001
2018-11-09	2018-11-08	4	Ward Robert	ONCS	Stock Option (Right to Buy)	A - Award	D	0,84		100 000		100 000
2018-11-08		3	Ward Robert	ONCS	Common Stock		D						0
2018-11-07	2018-11-07	4	O'Connor Daniel	ONCS	Common Stock	P - Purchase	D		0,9100	10 000	9		26 667
2018-10-18	2018-09-16	4	Bonstein Sara	ONCS	Common Stock	F - Taxes	D		1,5800	−15 405	−24		474 110
2018-07-18		3	Bonstein Sara	ONCS	Common Stock		D						0
2018-07-18	2018-07-16	4	Bonstein Sara	ONCS	Common Stock	F - Taxes	D		1,3400	−135 485	−182		489 515
2018-07-18	2018-07-16	4	Bonstein Sara	ONCS	Common Stock	A - Award	D			625 000			625 000
2018-07-09	2018-07-05	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3120	−32 000	−42		485 262
2018-07-09	2018-07-05	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3120	−13 785	−18		517 262
2018-07-09	2018-06-29	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3800	−5 401	−7		531 047
2018-07-09	2018-06-28	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4010	−7 882	−11		536 448
2018-07-09	2018-06-27	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3740	−17 480	−24		544 330
2018-07-09	2018-06-26	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3980	−23 820	−33		561 810
2018-07-09	2018-06-25	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4050	−1 021	−1		585 630
2018-07-09	2018-06-22	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4180	−14 976	−21		586 651
2018-07-09	2018-06-21	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4010	−11 035	−15		601 627
2018-07-09	2018-06-20	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4220	−55 585	−79		612 662
2018-07-09	2018-06-19	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3640	−9 310	−13		668 247
2018-07-09	2018-06-18	4/A	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3860	−28 145	−39		677 557
2018-07-09	2018-06-15	4/A	DHILLON PUNIT	ONCS	Restricted Stock Units	M - Exercise	D			−200 000		0
2018-07-09	2018-06-15	4/A	DHILLON PUNIT	ONCS	Restricted Stock Units	M - Exercise	D			−150 000		0
2018-07-09	2018-06-15	4/A	DHILLON PUNIT	ONCS	Restricted Stock Units	M - Exercise	D			−125 000		0
2018-07-09	2018-06-15	4/A	DHILLON PUNIT	ONCS	Common Stock	M - Exercise	D			200 000			705 702
2018-07-09	2018-06-15	4/A	DHILLON PUNIT	ONCS	Common Stock	M - Exercise	D			150 000			505 702
2018-07-09	2018-06-15	4/A	DHILLON PUNIT	ONCS	Common Stock	M - Exercise	D			125 000			355 702
2018-07-06	2018-02-06	4/A	DHILLON PUNIT	ONCS	Common Stock	A - Award	D		0,8800	3 000	3		230 702
2018-07-06	2018-07-05	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,3120	−3 100	−4		143 427
2018-07-06	2018-06-29	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,3800	−1 066	−1		146 527
2018-07-06	2018-06-28	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,4010	−1 556	−2		147 593
2018-07-06	2018-06-27	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,3740	−3 451	−5		149 149
2018-07-06	2018-06-26	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,3980	−4 703	−7		152 600
2018-07-06	2018-06-25	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,4050	−202	−0		157 303
2018-07-06	2018-06-22	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,4180	−2 956	−4		157 505
2018-07-06	2018-06-21	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,4010	−2 178	−3		160 461
2018-07-06	2018-06-20	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,4220	−10 973	−16		162 639
2018-07-06	2018-06-19	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,3640	−1 838	−3		173 612
2018-07-06	2018-06-18	4	DHILLON AVTAR S	ONCS	Common Stock	S - Sale	D		1,3860	−5 552	−8		175 450
2018-07-06	2018-06-15	4	DHILLON AVTAR S	ONCS	Restricted Stock Units	M - Exercise	D			−100 000		0
2018-07-06	2018-06-15	4	DHILLON AVTAR S	ONCS	Common Stock	M - Exercise	D			100 000			181 002
2018-07-06	2018-07-05	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,3120	−6 725	−9		270 016
2018-07-06	2018-06-29	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,3800	−2 420	−3		276 741
2018-07-06	2018-06-28	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,4010	−3 532	−5		279 161
2018-07-06	2018-06-27	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,3740	−7 832	−11		282 693
2018-07-06	2018-06-26	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,3980	−10 673	−15		290 525
2018-07-06	2018-06-25	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,4050	−458	−1		301 198
2018-07-06	2018-06-22	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,4180	−6 710	−10		301 656
2018-07-06	2018-06-21	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,4010	−4 944	−7		308 366
2018-07-06	2018-06-20	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,4220	−24 906	−35		313 310
2018-07-06	2018-06-19	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,3640	−4 171	−6		338 216
2018-07-06	2018-06-18	4	SLANSKY RICHARD B	ONCS	Common Stock	S - Sale	D		1,3860	−12 613	−17		342 387
2018-07-06	2018-06-15	4	SLANSKY RICHARD B	ONCS	Restricted Stock Units	M - Exercise	D			−100 000		0
2018-07-06	2018-06-15	4	SLANSKY RICHARD B	ONCS	Restricted Stock Units	M - Exercise	D			−100 000		0
2018-07-06	2018-06-15	4	SLANSKY RICHARD B	ONCS	Common Stock	M - Exercise	D			100 000			355 000
2018-07-06	2018-06-15	4	SLANSKY RICHARD B	ONCS	Common Stock	M - Exercise	D			100 000			355 000
2018-07-06	2018-07-05	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3120	−45 785	−60		485 262
2018-07-06	2018-06-29	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3800	−5 401	−7		531 047
2018-07-06	2018-06-28	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4010	−7 882	−11		536 448
2018-07-06	2018-06-27	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3740	−17 480	−24		544 330
2018-07-06	2018-06-26	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3980	−23 820	−33		561 810
2018-07-06	2018-06-25	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4050	−1 021	−1		585 630
2018-07-06	2018-06-22	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4180	−14 976	−21		586 651
2018-07-06	2018-06-21	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4010	−11 035	−15		601 627
2018-07-06	2018-06-20	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,4220	−55 585	−79		612 662
2018-07-06	2018-06-19	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3640	−9 310	−13		668 247
2018-07-06	2018-06-18	4	DHILLON PUNIT	ONCS	Common Stock	S - Sale	D		1,3860	−28 145	−39		677 557
2018-07-06	2018-06-15	4	DHILLON PUNIT	ONCS	Restricted Stock Units	M - Exercise	D			−200 000		0
2018-07-06	2018-06-15	4	DHILLON PUNIT	ONCS	Restricted Stock Units	M - Exercise	D			−150 000		0
2018-07-06	2018-06-15	4	DHILLON PUNIT	ONCS	Restricted Stock Units	M - Exercise	D			−125 000		0
2018-07-06	2018-06-15	4	DHILLON PUNIT	ONCS	Common Stock	M - Exercise	D			200 000			705 702
2018-07-06	2018-06-15	4	DHILLON PUNIT	ONCS	Common Stock	M - Exercise	D			150 000			505 702
2018-07-06	2018-06-15	4	DHILLON PUNIT	ONCS	Common Stock	M - Exercise	D			125 000			355 702
2018-05-07	2018-05-03	4	O'Connor Daniel	ONCS	Stock Option (Right to Buy)	A - Award	D	1,47	1,4700	250 000	368	2 850 000
2018-05-07	2018-05-03	4	SLANSKY RICHARD B	ONCS	Stock Option (Right to Buy)	A - Award	D	1,47	1,4700	100 000	147	447 500
2018-02-09	2018-02-08	4	DHILLON PUNIT	ONCS	Restricted Stock Units	A - Award	D			200 000		475 583
2018-02-09	2018-02-08	4	DHILLON PUNIT	ONCS	Option to Purchase Common Stock	A - Award	D	1,64	1,6400	300 000	492	1 114 583
2018-02-09	2018-02-08	4	DEMESA JAMES M	ONCS	Option to Purchase Common Stock	A - Award	D	1,64	1,6400	50 000	82	176 500
2018-02-09	2018-02-08	4	DHILLON AVTAR S	ONCS	Option to Purchase Common Stock	A - Award	D	1,64	1,6400	350 000	574	647 916
2018-02-06	2018-02-06	4	DHILLON PUNIT By the Dhillon Living Trust dated May 24, 2017	ONCS	Common Stock	P - Purchase	I		0,8800	3 000	3		230 702
2018-02-06	2018-02-05	4	O'Connor Daniel	ONCS	Common Stock	P - Purchase	D		1,5000	16 667	25		16 667
2018-01-17	2018-01-12	4	O'Connor Daniel	ONCS	Stock Option (Right to Buy)	A - Award	D	1,25		500 000		500 000
2018-01-17	2018-01-12	4	O'Connor Daniel	ONCS	Stock Option (Right to Buy)	A - Award	D	1,25		2 000 000		2 000 000
2018-01-17	2018-01-12	4	SLANSKY RICHARD B	ONCS	Stock Option (Right to Buy)	A - Award	D	1,32		100 000		347 500
2018-01-17	2018-01-12	4	DHILLON PUNIT	ONCS	Stock Option (Right to Buy)	A - Award	D	1,32		250 000		814 583
2018-01-17	2018-01-12	4	Mayes, Gregory T.	ONCS	Stock Option (Right to Buy)	A - Award	D	1,94		100 000		100 000
2017-09-11	2017-09-07	4	O'Connor Daniel	ONCS	Stock Option (Right to Buy)	A - Award	D	1,08		100 000		100 000
2017-09-05	2017-09-05	4	Jenkins Annalisa	ONCS	Stock Option (Right to Buy)	A - Award	D	0,98		100 000		100 000
2017-08-02	2017-07-31	4	DHILLON PUNIT By the Dhillon Living Trust dated May 24, 2016	ONCS	Common Stock	P - Purchase	I		0,8800	3 000	3		227 702
2017-08-02	2017-07-31	4	Mohan-Peterson Sheela	ONCS	Common Stock	P - Purchase	D		0,8800	3 000	3		9 520
2017-04-03	2017-03-29	4	MAIDA ANTHONY E III	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	20 000	27	131 500
2017-03-31	2017-03-29	4	SLANSKY RICHARD B	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	75 000	100	247 500
2017-03-31	2017-03-29	4	SLANSKY RICHARD B	ONCS	Restricted Stock Units	A - Award	D			100 000		200 000
2017-03-31	2017-03-29	4	Mohan-Peterson Sheela	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	75 000	100	180 125
2017-03-31	2017-03-29	4	Mohan-Peterson Sheela	ONCS	Restricted Stock Units	A - Award	D			100 000		200 000
2017-03-31	2017-03-29	4	DEMESA JAMES M	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	20 000	27	126 500
2017-03-31	2017-03-29	4	Gargosky Sharron E	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	75 000	100	345 000
2017-03-31	2017-03-29	4	Gargosky Sharron E	ONCS	Restricted Stock Units	A - Award	D			100 000		100 000
2017-03-31	2017-03-29	4	DHILLON PUNIT	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	150 000	201	564 583
2017-03-31	2017-03-29	4	DHILLON PUNIT	ONCS	Restricted Stock Units	A - Award	D			150 000		275 000
2017-03-31	2017-03-29	4	DHILLON AVTAR S	ONCS	Option to Purchase Common Stock	A - Award	D	1,34	1,3400	20 000	27	297 916
2017-02-02	2017-01-31	4	DHILLON PUNIT By the Dhillon Living Trust dated May 24, 2016	ONCS	Common Stock	P - Purchase	I		0,9900	3 000	3		224 702
2017-02-02	2017-01-31	4	Mohan-Peterson Sheela	ONCS	Common Stock	P - Purchase	D		0,9900	3 000	3		6 520
2016-12-16	2016-12-14	4	DHILLON AVTAR S	ONCS	Non-Qualified Stock Option (right to buy)	A - Award	D	1,29		265 416		265 416
2016-12-16	2016-12-14	4	DHILLON AVTAR S	ONCS	Non-Qualified Stock Option (right to buy)	D - Sale to Issuer	D	5,76		−500 000		0
2016-12-16	2016-12-14	4	DHILLON AVTAR S	ONCS	Non-Qualified Stock Option (right to buy)	D - Sale to Issuer	D	7,60		−12 500		0
2016-12-16	2016-12-14	4	DHILLON AVTAR S	ONCS	Non-Qualified Stock Option (right to buy)	D - Sale to Issuer	D	16,10		−12 500		0
2016-12-16	2016-12-14	4	DHILLON AVTAR S	ONCS	Non-Qualified Stock Option (right to buy)	D - Sale to Issuer	D	4,20		−5 000		0
2016-12-16	2016-12-14	4	DHILLON AVTAR S	ONCS	Non-Qualified Stock Option (right to buy)	D - Sale to Issuer	D	5,00		−5 000		0
2016-12-16	2016-12-14	4	DHILLON PUNIT	ONCS	Employee Stock Option (right to buy)	A - Award	D	1,29		314 583		314 583
2016-12-16	2016-12-14	4	DHILLON PUNIT	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	5,76		−500 000		0
2016-12-16	2016-12-14	4	DHILLON PUNIT	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	7,60		−25 000		0
2016-12-16	2016-12-14	4	DHILLON PUNIT	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	4,20		−25 000		0
2016-12-16	2016-12-14	4	DHILLON PUNIT	ONCS	Non-qualified Stock Option (right to buy)	D - Sale to Issuer	D	16,10		−100 000		0
2016-12-16	2016-12-14	4	DHILLON PUNIT	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	4,60		−12 500		0
2016-12-16	2016-12-14	4	SLANSKY RICHARD B	ONCS	Employee Stock Option (right to buy)	A - Award	D	1,29		112 500		112 500
2016-12-16	2016-12-14	4	SLANSKY RICHARD B	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	5,76		−75 000		0
2016-12-16	2016-12-14	4	SLANSKY RICHARD B	ONCS	Non-qualified Stock Option (right to buy)	D - Sale to Issuer	D	6,12		−150 000		0
2016-12-16	2016-12-14	4	Mohan-Peterson Sheela	ONCS	Employee Stock Option (right to buy)	A - Award	D	1,29		45 125		45 125
2016-12-16	2016-12-14	4	Mohan-Peterson Sheela	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	5,76		−74 000		0
2016-12-16	2016-12-14	4	Mohan-Peterson Sheela	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	7,60		−6 250		0
2016-12-16	2016-12-14	4	Mohan-Peterson Sheela	ONCS	Employee Stock Option (right to buy)	D - Sale to Issuer	D	8,80		−10 000		0
2016-08-05	2016-07-31	4	DHILLON PUNIT By the Dhillon Living Trust dated May 24, 2016	ONCS	Common Stock	P - Purchase	I		1,4400	3 000	4		765 501
2016-08-05	2016-07-31	4	Mohan-Peterson Sheela	ONCS	Common Stock	P - Purchase	D		1,4400	3 000	4		153 250
2016-03-08	2016-03-04	4/A	MAIDA ANTHONY E III	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	12 500	25	111 500
2016-03-08	2016-03-04	4	DHILLON PUNIT	ONCS	Restricted Stock Units	A - Award	D			125 000		125 000
2016-03-08	2016-03-04	4	DHILLON PUNIT	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	100 000	202	762 501
2016-03-08	2016-03-04	4	DHILLON AVTAR S	ONCS	Restricted Stock Units	A - Award	D			100 000		100 000
2016-03-08	2016-03-04	4	DHILLON AVTAR S	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	12 500	25	547 500
2016-03-08	2016-03-04	4	SLANSKY RICHARD B	ONCS	Restricted Stock Units	A - Award	D			100 000		100 000
2016-03-08	2016-03-04	4	SLANSKY RICHARD B	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	60 000	121	285 000
2016-03-08	2016-03-04	4	MAIDA ANTHONY E III	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	12 500	25	111 500
2016-03-08	2016-03-04	4	DEMESA JAMES M	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	12 500	25	106 500
2016-03-08	2016-03-04	4	Pierce Robert Hamilton	ONCS	Restricted Stock Units	A - Award	D			100 000		100 000
2016-03-08	2016-03-04	4	Pierce Robert Hamilton	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	100 000	202	341 500
2016-03-08	2016-03-04	4	Mohan-Peterson Sheela	ONCS	Restricted Stock Units	A - Award	D			100 000		100 000
2016-03-08	2016-03-04	4	Mohan-Peterson Sheela	ONCS	Option to Purchase Common Stock	A - Award	D	2,02	2,0200	60 000	121	150 250
2015-10-19	2015-10-16	4	DHILLON AVTAR S	ONCS	Common Stock	P - Purchase	D		4,3590	10 000	44		10 000
2015-10-19	2015-10-16	4	Mohan-Peterson Sheela	ONCS	Common Stock	P - Purchase	D		4,2400	520	2		520
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,1999	100	0		100
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,1999	473	2		473
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,3500	1 000	4		1 000
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,1999	100	0		100
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,1999	2 296	10		2 296
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,1999	1 231	5		1 231
2015-10-19	2015-10-16	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		4,2699	4 800	20		4 800
2015-08-24	2015-08-20	4	Le Mai Hope	ONCS	Option to purchase common stock	A - Award	D	5,67	5,6700	144 000	816	144 000
2015-08-24	2015-08-20	4	Pierce Robert Hamilton	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	144 000	816	144 000
2015-08-24	2015-08-20	4	Mohan-Peterson Sheela	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	74 000	420	74 000
2015-08-24	2015-08-20	4	DHILLON PUNIT	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	500 000	2 835	500 000
2015-08-24	2015-08-20	4	MAIDA ANTHONY E III	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	59 000	335	59 000
2015-08-24	2015-08-20	4	DHILLON AVTAR S	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	500 000	2 835	500 000
2015-08-24	2015-08-20	4	SLANSKY RICHARD B	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	75 000	425	75 000
2015-08-24	2015-08-20	4	DEMESA JAMES M	ONCS	Option to Purchase Common Stock	A - Award	D	5,67	5,6700	59 000	335	59 000
2015-07-09		3/A	SLANSKY RICHARD B	ONCS	Common Stock		D						5 000
2015-07-08		3	SLANSKY RICHARD B	ONCS	OncoSec Medical Inc		D						10 000
2015-07-08		3	SLANSKY RICHARD B	ONCS	OncoSec Medical Inc		D						10 000
2015-07-08	2015-07-06	4	SLANSKY RICHARD B	ONCS	OncoSec Medical Inc.	P - Purchase	D		6,1200	150 000	918		150 000
2015-06-11	2015-06-10	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		6,7250	1 100	7		2 500
2015-06-11	2015-06-10	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		6,7490	1 400	9		1 400
2015-03-04	2015-03-03	4	DEMESA JAMES M	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	250 000	92	250 000
2015-03-04	2015-03-03	4	VALLEJO VERONICA	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	250 000	92	250 000
2015-03-04	2015-03-03	4	DHILLON PUNIT	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	500 000	185	500 000
2015-03-04	2015-03-03	4	MAIDA ANTHONY E III	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	250 000	92	250 000
2015-03-04	2015-03-03	4	DHILLON AVTAR S	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	250 000	92	250 000
2015-03-04	2015-03-03	4	Le Mai Hope	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	250 000	92	250 000
2015-03-04	2015-03-03	4	Pierce Robert Hamilton	ONCS	Stock Option (Right to Buy)	A - Award	D	0,37	0,3700	250 000	92	250 000
2014-11-12	2014-09-16	4	Le Mai Hope	ONCS	Options to purchase common stock	A - Award	D	0,52	0,5200	1 700 000	884	1 700 000
2014-11-12		3	Le Mai Hope	ONCS	Common Stock		D						0
2014-03-20	2014-03-19	4	DHILLON PUNIT	ONCS	Common Stock	P - Purchase	D		0,8000	50 000	40		4 444 000
2014-03-20	2014-03-20	4	MAIDA ANTHONY E III By Daughter	ONCS	Common Stock	P - Purchase	I		0,8140	1 400	1		22 800
2014-03-20	2014-03-20	4	MAIDA ANTHONY E III By Daughter	ONCS	Common Stock	P - Purchase	I		0,8125	1 400	1		22 800
2014-03-20	2014-03-20	4	MAIDA ANTHONY E III By Spouse	ONCS	Common Stock	P - Purchase	I		0,8150	18 000	15		22 800
2014-03-20	2014-03-20	4	MAIDA ANTHONY E III By Spouse	ONCS	Common Stock	P - Purchase	I		0,8100	1 000	1		22 800
2014-03-20	2014-03-20	4	MAIDA ANTHONY E III By Spouse	ONCS	Common Stock	P - Purchase	I		0,8075	1 000	1		22 800
2014-03-11	2014-03-07	4	MAIDA ANTHONY E III	ONCS	Stock Option (Right to Buy)	A - Award	D	0,80	0,8050	250 000	201	250 000
2014-03-11	2014-03-07	4	DHILLON AVTAR S	ONCS	Stock Option (Right to Buy)	A - Award	D	0,80	0,8050	250 000	201	250 000
2014-03-11	2014-03-07	4	DHILLON PUNIT	ONCS	Stock Option (Right to Buy)	A - Award	D	0,80	0,8050	2 000 000	1 610	2 000 000
2014-03-11	2014-03-07	4	DEMESA JAMES M	ONCS	Stock Option (Right to Buy)	A - Award	D	0,80	0,8050	250 000	201	250 000
2014-03-11	2014-03-07	4	VALLEJO VERONICA	ONCS	Stock Option (Right to Buy)	A - Award	D	0,80	0,8050	1 000 000	805	1 000 000
2014-02-10		3	Pierce Robert Hamilton	ONCS	Common Stock		D						0
2014-02-10	2013-12-11	4	Pierce Robert Hamilton	ONCS	Common Stock	A - Award	D	0,31	0,3100	1 700 000	527	1 700 000
2013-04-16	2013-04-15	4	MAIDA ANTHONY E III	ONCS	Stock Options (Right to Buy)	A - Award	D	0,25		100 000		100 000
2013-04-16	2013-04-15	4	DHILLON AVTAR S	ONCS	Stock Options (Right to Buy)	A - Award	D	0,25		100 000		100 000
2013-04-16	2013-04-15	4	DEMESA JAMES M	ONCS	Stock Options (Right to Buy)	A - Award	D	0,25		100 000		100 000
2013-02-12	2013-02-08	4	DHILLON PUNIT	ONCS	Stock Options (Right to Buy)	A - Award	D	0,23		250 000		250 000
2013-02-12	2013-02-08	4	VALLEJO VERONICA	ONCS	Stock Options (Right to Buy)	A - Award	D	0,23		100 000		100 000
2012-04-27	2012-04-25	4	DHILLON PUNIT	ONCS.OB	Stock Options (Right to Buy)	A - Award	D	0,21		500 000		500 000
2012-04-27	2012-04-25	4	DHILLON AVTAR S	ONCS.OB	Stock Options (Right to Buy)	A - Award	D	0,21		100 000		100 000
2012-04-27	2012-04-25	4	MAIDA ANTHONY E III	ONCS.OB	Stock Options (Right to Buy)	A - Award	D	0,21		100 000		100 000
2012-04-27	2012-04-25	4	DEMESA JAMES M	ONCS.OB	Stock Options (Right to Buy)	A - Award	D	0,21		100 000		100 000
2012-04-27	2012-04-25	4	VALLEJO VERONICA	ONCS.OB	Stock Options (Right to Buy)	A - Award	D	0,21		150 000		150 000

Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.

Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)

Konvertering av derivat

Salg eller overføring av verdipapirer tilbake til selskapet

Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet

Gave av verdipapirer fra eller til insidere

Aksjebytting og lignende sikringsavtaler

Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)

En transaksjon frivilig rapportert på Skjema 4

Annet (med en fotnote som beskriver transaksjonen)

ONCS / OncoSec Medical Inc - Insider Trading and Ownership Report - SEC Form 3, 4, 5